The successful conclusion of the 2023 Russian Health Care Exhibition marks another important milestone for Diagreat Biotech in its overseas market expansion. During this year, Diagreat Biotech actively embraced the international stage and participated in many international medical exhibitions such as Medlab Middle East in Dubai, United Arab Emirates, MEDICAL FAIR INDIA in New Delhi, India, and Medica in Dusseldorf, Germany, showing research and development technology achievements of Diagreat Biotech to the world.
At these exhibitions, Diagreat Biotech not only showcased its core technologies and products, but also established a broader international cooperation network through in-depth exchanges and negotiations with experts and scholars from all over the world. These exchanges not only helped Diagreat Biotech gain an in-depth understanding of the needs and trends of the global market, but also brought it more cooperation opportunities and projects.
In the future, Diagreat Biotech will further increase investment in research and development, expand the global market, and work hand in hand with partners from various countries to jointly create a better future. In this era full of opportunities and challenges, Diagreat Biotech will continue to uphold the concepts of openness, innovation and collaboration, actively expand overseas markets, and bring more benefits to patients around the world.